Surface-enhanced raman nanobiosensor
The present invention relates to biosensors, in particular to surface-enhanced Raman biosensors for detection of in vivo and ex vivo analytes. In particular, the present invention provides compositions and methods for the in vivo detection of analytes such as glucose.
1. A method for the in vivo determination of glucose concentration, comprising:
a) contacting an implanted biosensor with a bodily fluid to create a biosensor-glucose ensemble:
i) wherein said bodily fluid comprises glucose,
ii) wherein said implanted biosensor comprises,
1. a substrate,
2. nanospheres, said nanospheres in contact with said substrate,
3. a metal film, said metal film formed over said nanospheres, and
4. a self-assembled mixed partition layer, said self-assembled mixed partition layer adhered to said metal film, said self-assembled mixed partition layer comprising at least two discrete compounds,
a. said two discrete compounds comprising decanethiol and mercaptohexanol, and
iii) wherein said glucose concentrates within the self-assembled mixed partition layer in close physical proximity to the metal film;
b) directly detecting said glucose in said biosensor-glucose ensemble with surface-enhanced Raman spectroscopy to create a surface-enhanced Raman signal; and
c) correlating said surface-enhanced Raman signal to the concentration of said glucose in said bodily fluid.
2. The method of claim 1 , wherein said nanospheres comprise polystyrene or silica nanospheres.
3. The method of claim 1 , wherein said implanted biosensor further comprises a receptor, said receptor attached to said self-assembled mixed partition layer, said receptor specific for said glucose, and wherein said receptor is configured to bind reversibly to glucose.
4. The method of claim 1 , wherein said substrate is copper or silicon dioxide.
5. The method of claim 1 wherein said bodily fluid is blood.
6. The method of claim 1 wherein said bodily fluid is plasma.
7. The method of claim 1 wherein said bodily fluid is serum.
8. The method of claim 1 wherein said bodily fluid is interstitial fluid.
9. The method of claim 1 wherein said bodily fluid is extracellular fluid.
10. The method of claim 1 wherein close physical proximity comprises 1-2 nm.